EP2024395A4 - Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases - Google Patents

Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases

Info

Publication number
EP2024395A4
EP2024395A4 EP07797656A EP07797656A EP2024395A4 EP 2024395 A4 EP2024395 A4 EP 2024395A4 EP 07797656 A EP07797656 A EP 07797656A EP 07797656 A EP07797656 A EP 07797656A EP 2024395 A4 EP2024395 A4 EP 2024395A4
Authority
EP
European Patent Office
Prior art keywords
diagnostic
vascular diseases
natriuretic peptides
prognostic indicators
prognostic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07797656A
Other languages
German (de)
French (fr)
Other versions
EP2024395A2 (en
Inventor
Kenneth F Buechler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alere San Diego Inc
Original Assignee
Biosite Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosite Inc filed Critical Biosite Inc
Publication of EP2024395A2 publication Critical patent/EP2024395A2/en
Publication of EP2024395A4 publication Critical patent/EP2024395A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/323—Arteriosclerosis, Stenosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP07797656A 2006-05-26 2007-05-22 Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases Withdrawn EP2024395A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80865506P 2006-05-26 2006-05-26
PCT/US2007/069475 WO2007140188A2 (en) 2006-05-26 2007-05-22 Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases

Publications (2)

Publication Number Publication Date
EP2024395A2 EP2024395A2 (en) 2009-02-18
EP2024395A4 true EP2024395A4 (en) 2009-07-01

Family

ID=38779325

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07797656A Withdrawn EP2024395A4 (en) 2006-05-26 2007-05-22 Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases

Country Status (2)

Country Link
EP (1) EP2024395A4 (en)
WO (1) WO2007140188A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8492107B2 (en) 2004-04-15 2013-07-23 University Of Florida Research Foundation, Inc. Neural proteins as biomarkers for nervous system injury and other neural disorders
NO2324360T3 (en) 2008-08-11 2018-06-30
AU2010291933B2 (en) 2009-09-14 2016-09-08 Banyan Biomarkers, Inc. Micro-RNA, autoantibody and protein markers for diagnosis of neuronal injury
AU2011375306A1 (en) 2011-08-12 2014-02-27 Alfred Health Method for diagnosis, prognosis or treatment of acute coronary syndrome (ACS) comprising measurement of plasma concentration of macrophage migration inhibitory factor (MIF)
EP3688466A4 (en) * 2017-09-30 2021-05-19 Alfred Health Method of prognosis
WO2020089282A1 (en) * 2018-10-31 2020-05-07 Centro Nacional De Investigaciones Cardiovasculares Carlos Iii (F.S.P.) Biomarkers of subclinical atherosclerosis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040253637A1 (en) * 2001-04-13 2004-12-16 Biosite Incorporated Markers for differential diagnosis and methods of use thereof
WO2006029369A2 (en) * 2004-09-09 2006-03-16 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040203083A1 (en) * 2001-04-13 2004-10-14 Biosite, Inc. Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040253637A1 (en) * 2001-04-13 2004-12-16 Biosite Incorporated Markers for differential diagnosis and methods of use thereof
WO2006029369A2 (en) * 2004-09-09 2006-03-16 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ABDULLAH ET AL: "Relation of Coronary Atherosclerosis Determined by Electron Beam Computed Tomography and Plasma Levels of N-terminal Pro-Brain Natriuretic Peptide in a Multiethnic Population-Based Sample (The Dallas Heart Study)", AMERICAN JOURNAL OF CARDIOLOGY, CAHNERS PUBLISHING CO., NEWTON, MA, US, vol. 96, no. 9, 1 November 2005 (2005-11-01), pages 1284 - 1289, XP005129829, ISSN: 0002-9149 *
ASHLEY KELLAN E ET AL: "Brain natriuretic peptides as biomarkers for atherosclerosis.", PREVENTIVE CARDIOLOGY SUMMER 2008, vol. 11, no. 3, July 2008 (2008-07-01), pages 172 - 176, XP002528148, ISSN: 1520-037X *
PALAZZUOLI A ET AL: "Plasma brain natriuretic peptide levels in coronary heart disease with preserved systolic function", CLINICAL AND EXPERIMENTAL MEDICINE, vol. 4, no. 1, September 2004 (2004-09-01), pages 44 - 49, XP002528147, ISSN: 1591-8890 *
POLK DONNA M ET AL: "B-type natriuretic peptide, subclinical atherosclerosis and prognosis", CIRCULATION, vol. 114, no. 18, Suppl. S, October 2006 (2006-10-01), & 79TH ANNUAL SCIENTIFIC SESSION OF THE AMERICAN-HEART-ASSOCIATION; CHICAGO, IL, USA; NOVEMBER 12 -15, 2006, pages 725 - 726, XP008084065, ISSN: 0009-7322 *

Also Published As

Publication number Publication date
EP2024395A2 (en) 2009-02-18
WO2007140188A2 (en) 2007-12-06
WO2007140188A3 (en) 2008-07-10

Similar Documents

Publication Publication Date Title
EP2064550A4 (en) Prrg4-associated compositions and methods of use thereof in methods of tumor diagnosis
EP1904836A4 (en) Diagnostic strip coding system and related methods of use
PT2291394T (en) Fusion proteins and their use in the diagnosis and treatment of leishmaniasis
HK1120813A1 (en) Antibodies against human il-22 and uses therefor
IL193604A (en) Use of antibodies against human il-22 for the manufacture of medicaments
PL2614832T3 (en) Diagnosis and treatment of preeclampsia
GB0708585D0 (en) Novel antibody and use in diagnosis and therapy of arthropathies
IL197501A0 (en) Modifications of cupredoxin derived peptides and methods of use thereof
EP2036566A4 (en) Use of 20(s)-protopanoxadiol in manufacture of antidepressants
IL205398A0 (en) New antibodies specific of the ?? - amyloid peptides and their uses as diagnostic agents or drugs
EP2024395A4 (en) Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases
GB2443336B (en) Spiruchostatin analogues and their medicinal use
HK1108614A1 (en) Human body composition analyzer
EP2195645A4 (en) Identification of proteins in human serum indicative of pathologies of human lung tissues
HK1168283A1 (en) Sorcs1-like agent for use in the treatment of insulin resistance and diseases related thereto sorcs1
GB2460178B (en) Depsipeptides and their therapeutic use
IL195817A0 (en) Use of 2-benzoyl-imidazopyridines in therapeutics
EP1976426A4 (en) Medical diagnostic system and methods
EP2097093A4 (en) Therapeutic and diagnostic peptides
GB2460181B (en) Depsipeptides and their therapeutic use
GB0602110D0 (en) Use of ultrasound in the diagnosis and treatment of multiple sclerosis
PL2291657T3 (en) Levels of blys/april heterotrimers in serum and use in diagnostic methods
EP2484693A4 (en) Human serum amyloid-a3 antibody and use thereof
EP1991874A4 (en) Diagnostic kits to detect sp22 and sp22 antibodies
GB2460180B (en) Depsipeptides and their therapeutic use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20081217

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20090602

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20090908